ArticleNature communications2025

Co-delivery of sorafenib and an FSP1 inhibitor triggers dual ferroptosis in tumor cells and immunosuppressive macrophages for enhanced immunotherapy in mouse models of hepatocellular carcinoma.

Chuanyu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.